Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours Β· Estimated delivery Oct 20 - Oct 25
COMPOUNDED LIRAGLUTIDE BENEFITS Do more, age less Contains Liraglutide as the primary active ingredient Daily GLP-1 injectable for continuous appetite regulation and blood sugar control Targets the GLP-1 hormone receptors to reduce appetite and cravings Liraglutide mimics the natural GLP-1 hormone, which plays a key role in blood sugar and appetite control Clinical trials show patients lose between 5-10% body weight Use with reduced-calorie meal plan and exercise for best results * Compounded Liraglutide has not been reviewed or approved by the FDA or analyzed by any available scientific study
Originally developed for diabetes, semaglutide prompts the pancreas to release insulin by mimicking a hormone called GLP-1, or glucagon-like peptide 1
Kalyan Aluri is a trusted family physician with over 25 years of experience in urgent and primary care settings
set a phone reminder if it helps
The FDA-approved prescribing information for tirzepatide explicitly states that "there are no data on the presence of tirzepatide in human milk, the effects on the breastfed infant, or the effects on milk production." This absence of data reflects the exclusion of pregnant and breastfeeding individuals from clinical trials, a common practice that creates knowledge gaps for this population
